文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

高甘油三酯血症相关急性胰腺炎患者的早期血浆置换

Early Plasmapheresis Among Patients With Hypertriglyceridemia-Associated Acute Pancreatitis.
PubMed 文献 · JAMA Netw Open · 2023-06-01
一句话结论多中心前瞻性队列显示,HTG-AP患者接受血浆置换与无器官衰竭天数无差异,但与ICU入住需求增加相关。

该研究为多中心前瞻性队列的事先分析,纳入中国28个中心267例发病72小时内入院的高甘油三酯血症相关急性胰腺炎(HTG-AP)患者,其中56例接受血浆置换、211例仅常规内科治疗。倾向评分匹配后47对患者中,血浆置换组与未置换组的无器官衰竭天数无差异(中位数12.0天 vs 13.0天,P=0.94),但血浆置换组ICU入住比例更高(93.6% vs 51.1%,P<0.001),逆概率加权分析结果与之一致。作者结论认为,校正混杂因素后血浆置换与器官衰竭发生及持续时间无关,却与ICU需求增加相关。

要点

  • 267例HTG-AP患者中56例接受血浆置换,匹配后无器官衰竭天数与未置换组无差异(12.0天 vs 13.0天,P=0.94)。
  • 匹配队列中血浆置换组ICU入住比例显著更高(44/47,93.6% vs 24/47,51.1%;P<0.001)。
  • 逆概率加权(IPTW)分析结果与倾向评分匹配分析一致。
  • 研究纳入28个中心、发病72小时内入院的HTG-AP患者,首例2020年11月7日入组,末例2021年11月30日入组。
  • 作者结论:校正混杂后血浆置换与器官衰竭发生及持续时间无关,但与ICU需求增加相关。

适用人群与场景

  • 中国28个中心收治的HTG-AP患者,发病72小时内入院。
  • 共267例,男性185例(69.3%),中位年龄37岁(IQR 31-43岁)。

处置流程与药物剂量

  • 血浆置换作为降低甘油三酯的治疗选择之一,是否采用由主治医师决定;降甘油三酯治疗的选择同样由主治医师决定。
  • 211例接受常规内科治疗,56例接受血浆置换。

研究设计与关键结果

  • 研究类型为多中心前瞻性队列研究的事先分析,纳入28个中心267例HTG-AP患者;血浆置换组56例,常规内科治疗组211例;采用倾向评分匹配(PSM)和逆概率加权(IPTW)控制混杂。
  • PSM匹配后47对患者基线特征均衡;血浆置换组与未置换组无器官衰竭天数无差异(中位数12.0天[IQR 8.0-14.0] vs 13.0天[IQR 8.0-14.0];P=0.94)。
  • 匹配队列中血浆置换组ICU入住比例高于未置换组(44/47,93.6% vs 24/47,51.1%;P<0.001)。
  • IPTW分析结果与PSM分析一致。
  • 次要终点包括ICU入住、ICU与住院时间、感染性胰腺坏死发生率及60天死亡率,原文摘要未报告这些终点的具体数值。

证据类型、等级与局限

  • 证据类型:多中心前瞻性队列研究的事先分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,校正混杂因素后血浆置换与器官衰竭发生及持续时间无关,但与ICU需求增加相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The incidence of hypertriglyceridemia-associated acute pancreatitis (HTG-AP) is increasing. Plasmapheresis is theoretically effective in removing triglyceride from plasma, but whether it confers clinical benefits is unclear.

OBJECTIVE: To assess the association between plasmapheresis and the incidence and duration of organ failure among patients with HTG-AP.

DESIGN, SETTING, AND PARTICIPANTS: This is an a priori analysis of data from a multicenter, prospective cohort study with patients enrolled from 28 sites across China. Patients with HTG-AP were admitted within 72 hours from the disease onset. The first patient was enrolled on November 7th, 2020, and the last on November 30th, 2021. The follow-up of the 300th patient was completed on January 30th, 2022. Data were analyzed from April to May 2022.

EXPOSURES: Receiving plasmapheresis. The choice of triglyceride-lowering therapies was at the discretion of the treating physicians.

MAIN OUTCOMES AND MEASURES: The primary outcome was organ failure-free days to 14 days of enrollment. Secondary outcomes included other measures for organ failure, intensive care unit (ICU) admission, duration of ICU and hospital stays, incidence of infected pancreatic necrosis, and 60-day mortality. Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) analyses were used to control potential confounders.

RESULTS: Overall, 267 patients with HTG-AP were enrolled (185 [69.3%] were male; median [IQR] age, 37 [31-43] years), among whom 211 underwent conventional medical treatment and 56 underwent plasmapheresis. PSM created 47 pairs of patients with balanced baseline characteristics. In the matched cohort, no difference was detected concerning organ failure-free days between patients undergoing plasmapheresis or not (median [IQR], 12.0 [8.0-14.0] vs 13.0 [8.0-14.0]; P = .94). Moreover, more patients in the plasmapheresis group required ICU admission (44 [93.6%] vs 24 [51.1%]; P < .001). The IPTW results conformed to the results from the PSM analysis.

CONCLUSIONS AND RELEVANCE: In this large multicenter cohort study of patients with HTG-AP, plasmapheresis was commonly used to lower plasma triglyceride. However, after adjusting for confounders, plasmapheresis was not associated with the incidence and duration of organ failure, but with increased ICU requirements.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Cao L, Chen Y, Liu S, et al. Early Plasmapheresis Among Patients With Hypertriglyceridemia-Associated Acute Pancreatitis. JAMA Netw Open. 2023. PMID: 37378979. doi:10.1001/jamanetworkopen.2023.20802

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。